1. Ohsugi, Takeo. 2017. Effects of expressing human T-cell leukemia virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice. In The Journal of veterinary medical science, 79, 935-938. doi:10.1292/jvms.17-0034. https://pubmed.ncbi.nlm.nih.gov/28302940/
2. Coppin, Emilie, De Grandis, Maria, Pandolfi, Pier Paolo, Aurrand-Lions, Michel, Nunès, Jacques A. 2016. Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells. In Journal of immunology (Baltimore, Md. : 1950), 196, 4110-21. doi:10.4049/jimmunol.1501037. https://pubmed.ncbi.nlm.nih.gov/27183638/
3. Tanaka, Yuka, Kulkeaw, Kasem, Inoue, Tomoko, Shirasawa, Senji, Sugiyama, Daisuke. . Dok2 likely down-regulates Klf1 in mouse erythroleukemia cells. In Anticancer research, 34, 4561-7. doi:. https://pubmed.ncbi.nlm.nih.gov/25075100/
4. Berger, Alice H, Chen, Ming, Morotti, Alessandro, Varmus, Harold E, Pandolfi, Pier Paolo. 2013. DOK2 inhibits EGFR-mutated lung adenocarcinoma. In PloS one, 8, e79526. doi:10.1371/journal.pone.0079526. https://pubmed.ncbi.nlm.nih.gov/24255704/
5. Miyagaki, Hiromichi, Yamasaki, Makoto, Takahashi, Tsuyoshi, Mori, Masaki, Doki, Yuichiro. 2011. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection. In Annals of surgical oncology, 19, 1560-7. doi:10.1245/s10434-011-2157-6. https://pubmed.ncbi.nlm.nih.gov/22130622/
6. Celis-Gutierrez, Javier, Boyron, Marilyn, Walzer, Thierry, Vivier, Eric, Nunès, Jacques A. 2014. Dok1 and Dok2 proteins regulate natural killer cell development and function. In The EMBO journal, 33, 1928-40. doi:10.15252/embj.201387404. https://pubmed.ncbi.nlm.nih.gov/24963146/
7. Xu, Jiaxuan, Dong, Xiaoqing, Wang, Ruoyi, Chen, Bing. 2022. DOK2 Has Prognostic and Immunologic Significance in Adults With Acute Myeloid Leukemia: A Novel Immune-Related Therapeutic Target. In Frontiers in medicine, 9, 842383. doi:10.3389/fmed.2022.842383. https://pubmed.ncbi.nlm.nih.gov/35321466/
智鼠故事 
